name: Central Core Myopathy
category: Mendelian
description: >
  Central core myopathy (central core disease, CCD) is a congenital myopathy caused
  predominantly by mutations in the RYR1 gene encoding the skeletal muscle ryanodine
  receptor (RyR1), the principal sarcoplasmic reticulum calcium release channel.
  It is characterized histopathologically by central cores â€” areas of sarcomeric
  disorganization and mitochondrial depletion running along the longitudinal axis
  of type 1 muscle fibers. Clinical features include proximal muscle weakness,
  hypotonia, delayed motor milestones, orthopaedic complications, and susceptibility
  to malignant hyperthermia. Inheritance is most commonly autosomal dominant with
  incomplete penetrance and variable expressivity, though autosomal recessive forms
  exist and tend to be more severe. First described by Shy and Magee in 1956, CCD
  was the first congenital myopathy defined by a specific histological abnormality.
disease_term:
  preferred_term: central core myopathy
  term:
    id: MONDO:0007294
    label: central core myopathy
parents:
  - Congenital myopathy
  - RYR1-related myopathy
inheritance:
  - name: Autosomal dominant
    inheritance_term:
      preferred_term: Autosomal dominant inheritance
      term:
        id: HP:0000006
        label: Autosomal dominant inheritance
    penetrance: INCOMPLETE
    expressivity: VARIABLE
    description: >
      Most cases of central core myopathy follow autosomal dominant inheritance
      with incomplete penetrance and variable expressivity. Dominant mutations
      are typically missense changes clustered in recognized mutational hotspot
      regions including the C-terminal transmembrane/pore-forming domain and
      tend to cause a milder phenotype.
    evidence:
      - reference: PMID:22473935
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Dominant mutations, typically missense, were frequently located in
          recognized mutational hotspot regions, while recessive mutations were
          distributed throughout the entire coding sequence.
        explanation: >
          Large cohort study of 71 families confirms that dominant RYR1 mutations
          are typically missense and cluster in hotspot regions.
      - reference: PMID:8220422
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Central core disease (CCD) is a morphologically distinct, autosomal
          dominant myopathy with variable clinical features.
        explanation: >
          The landmark 1993 Nature Genetics paper establishing the RYR1 link
          describes CCD as autosomal dominant with variable features.
  - name: Autosomal recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
    description: >
      Autosomal recessive forms of central core myopathy tend to be more severe,
      with earlier onset, greater weakness, and more functional limitations.
      Extraocular and bulbar muscle involvement is almost exclusively observed
      in recessive cases. Recessive mutations are distributed throughout the
      RYR1 coding sequence and often include nonsense and splice mutations
      expected to result in reduced RyR1 protein expression.
    evidence:
      - reference: PMID:22473935
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          As a group, dominant mutations were associated with milder phenotypes;
          patients with recessive inheritance had earlier onset, more weakness,
          and functional limitations. Extraocular and bulbar muscle involvement
          was almost exclusively observed in the recessive group.
        explanation: >
          This large cohort study of 71 families (35 dominant, 36 recessive)
          demonstrates the clinical distinction between dominant and recessive
          RYR1-related myopathies.
pathophysiology:
  - name: Abnormal RyR1 calcium release channel function
    description: >
      RYR1 mutations alter the function of the ryanodine receptor, the principal
      calcium release channel of the sarcoplasmic reticulum in skeletal muscle.
      Dominant missense variants often produce hypersensitive or leaky RyR1
      channels with lowered threshold for sarcoplasmic reticulum calcium release,
      while recessive mutations frequently result in reduced RyR1 protein
      expression or excitation-contraction coupling uncoupling. Both mechanisms
      disrupt the DHPR-RyR1 signaling axis and calcium homeostasis in skeletal
      muscle fibers.
    gene:
      preferred_term: RYR1
      description: >
        Ryanodine receptor 1, a large homotetrameric calcium release channel of
        the sarcoplasmic reticulum that is fundamental to excitation-contraction
        coupling and skeletal muscle calcium homeostasis.
      modifier: ABNORMAL
      term:
        id: hgnc:10483
        label: RYR1
    cell_types:
      - preferred_term: Skeletal muscle fiber
        term:
          id: CL:0008002
          label: skeletal muscle fiber
      - preferred_term: Slow muscle cell (type I fiber)
        term:
          id: CL:0000189
          label: slow muscle cell
    biological_processes:
      - preferred_term: Regulation of SR calcium release
        term:
          id: GO:0010880
          label: regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
      - preferred_term: Calcium ion homeostasis
        term:
          id: GO:0055074
          label: calcium ion homeostasis
      - preferred_term: Regulation of skeletal muscle contraction by calcium signaling
        term:
          id: GO:0014722
          label: regulation of skeletal muscle contraction by calcium ion signaling
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Altered excitability and/or changes in calcium homeostasis within muscle
          cells due to mutation-induced conformational changes of the RyR protein
          are considered the main pathogenetic mechanism(s).
        explanation: >
          Comprehensive Orphanet review of CCD establishing that mutation-induced
          conformational changes in RyR1 leading to altered calcium homeostasis
          are the main pathogenetic mechanism.
      - reference: PMID:16917943
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          The RYR1 gene encodes the skeletal muscle isoform ryanodine receptor
          and is fundamental to the process of excitation-contraction coupling and
          skeletal muscle calcium homeostasis.
        explanation: >
          Review of RYR1 mutations in MH and CCD confirming the role of RYR1 in
          excitation-contraction coupling and calcium homeostasis.
      - reference: PMID:16917943
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          In vitro analysis has confirmed that alteration of normal calcium
          homeostasis is a functional consequence of some of these changes.
        explanation: >
          Confirms functional evidence that RYR1 mutations alter calcium
          homeostasis through in vitro studies.
  - name: Mitochondrial depletion and oxidative metabolism deficiency in cores
    description: >
      The central cores that define this myopathy histologically represent focal
      regions of myofibrillar disorganization with depletion of mitochondria and
      absence of oxidative enzyme activity. Cores run along the longitudinal axis
      of type 1 muscle fibers and are visualized as unstained regions on NADH-TR
      and cytochrome oxidase histochemistry. Mitochondrial calcium overload from
      dysfunctional RyR1 channels generates energetic strain and oxidative stress,
      contributing to the ultrastructural disorganization characteristic of cores.
    cell_types:
      - preferred_term: Skeletal muscle fiber
        term:
          id: CL:0008002
          label: skeletal muscle fiber
    biological_processes:
      - preferred_term: Response to oxidative stress
        term:
          id: GO:0006979
          label: response to oxidative stress
      - preferred_term: Intracellular calcium ion homeostasis
        term:
          id: GO:0006874
          label: intracellular calcium ion homeostasis
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Central core disease (CCD) is an inherited neuromuscular disorder
          characterised by central cores on muscle biopsy and clinical features
          of a congenital myopathy.
        explanation: >
          Establishes the defining histopathological feature of CCD as central
          cores on muscle biopsy.
  - name: Malignant hyperthermia susceptibility
    description: >
      RYR1 mutations predispose to malignant hyperthermia (MH), a pharmacogenetic
      disorder triggered by volatile anesthetic agents and succinylcholine. The
      susceptible RyR1 channel exhibits exaggerated calcium release in response
      to these triggers, causing sustained muscle contraction, hypermetabolism,
      rhabdomyolysis, and potentially fatal hyperthermia. CCD and MHS are allelic
      conditions and a single RYR1 mutation may result in either or both
      phenotypes.
    biological_processes:
      - preferred_term: Muscle contraction
        term:
          id: GO:0006936
          label: muscle contraction
      - preferred_term: Calcium ion homeostasis
        term:
          id: GO:0055074
          label: calcium ion homeostasis
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          CCD and MHS are allelic conditions both due to (predominantly dominant)
          mutations in the skeletal muscle ryanodine receptor (RYR1) gene,
          encoding the principal skeletal muscle sarcoplasmic reticulum calcium
          release channel (RyR1).
        explanation: >
          Establishes that CCD and MHS are allelic conditions caused by mutations
          in the same RYR1 gene.
      - reference: PMID:8220423
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          One of these mutations was also detected in an unrelated MH pedigree
          whose members are asymptomatic of CCD. The data suggest a model to
          explain how a single mutation may result in two apparently distinct
          clinical phenotypes.
        explanation: >
          Demonstrates that the same RYR1 mutation can cause CCD in one family
          and isolated MH susceptibility in another, establishing the allelic
          relationship.
phenotypes:
  - name: Proximal muscle weakness
    description: >
      Predominantly proximal muscle weakness affecting hip girdle and shoulder
      girdle muscles is a hallmark feature. Weakness is pronounced in the hip
      girdle and is typically static or only slowly progressive.
    frequency: HP_0040281
    phenotype_term:
      preferred_term: Proximal muscle weakness
      term:
        id: HP:0003701
        label: Proximal muscle weakness
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          CCD typically presents in infancy with hypotonia and motor developmental
          delay and is characterized by predominantly proximal weakness pronounced
          in the hip girdle
        explanation: >
          Comprehensive review establishing proximal weakness pronounced in the
          hip girdle as a characteristic feature of CCD.
      - reference: PMID:29391587
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Pronounced weakness in axial and proximal muscle groups is a common
          feature
        explanation: >
          Major Nature Reviews Neurology review confirming axial and proximal
          weakness as common in congenital myopathies including CCD.
  - name: Neonatal hypotonia
    description: >
      Hypotonia present from birth is a common presenting feature, often leading
      to the initial clinical evaluation. Severity ranges from mild to marked,
      with recessive forms tending to be more severe.
    frequency: HP_0040282
    phenotype_term:
      preferred_term: Neonatal hypotonia
      term:
        id: HP:0001319
        label: Neonatal hypotonia
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          CCD typically presents in infancy with hypotonia and motor
          developmental delay
        explanation: >
          Establishes infantile hypotonia as a typical presenting feature of CCD.
  - name: Delayed gross motor development
    description: >
      Motor development is typically delayed, with late achievement of sitting,
      standing, and independent ambulation. Most patients eventually achieve
      independent walking, though this may be delayed.
    frequency: HP_0040282
    phenotype_term:
      preferred_term: Delayed gross motor development
      term:
        id: HP:0002194
        label: Delayed gross motor development
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          CCD typically presents in infancy with hypotonia and motor
          developmental delay
        explanation: >
          Motor developmental delay is identified as a typical presenting feature.
  - name: Scoliosis
    description: >
      Scoliosis is a common orthopaedic complication that may require surgical
      correction in severe cases.
    frequency: HP_0040282
    phenotype_term:
      preferred_term: Scoliosis
      term:
        id: HP:0002650
        label: Scoliosis
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          orthopaedic complications are common
        explanation: >
          Orthopaedic complications including scoliosis are identified as common
          in CCD.
  - name: Congenital hip dislocation
    description: >
      Congenital hip dislocation is a characteristic orthopaedic complication
      and may be the presenting feature of the disease.
    frequency: HP_0040282
    phenotype_term:
      preferred_term: Congenital hip dislocation
      term:
        id: HP:0001374
        label: Congenital hip dislocation
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          orthopaedic complications are common
        explanation: >
          Congenital hip dislocation is one of the common orthopaedic
          complications in CCD.
  - name: Malignant hyperthermia susceptibility
    description: >
      Susceptibility to malignant hyperthermia episodes triggered by volatile
      anesthetics or depolarizing muscle relaxants is a frequent and potentially
      life-threatening complication requiring precautionary measures for all
      surgical procedures.
    frequency: HP_0040282
    phenotype_term:
      preferred_term: Malignant hyperthermia
      term:
        id: HP:0002047
        label: Malignant hyperthermia
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          malignant hyperthermia susceptibility (MHS) is a frequent complication
        explanation: >
          Establishes MHS as a frequent complication of CCD.
      - reference: PMID:8220423
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Central core disease (CCD) of muscle is an inherited myopathy which is
          closely associated with malignant hyperthermia (MH) in humans.
        explanation: >
          Confirms the close association between CCD and MH.
  - name: Myopathic facies
    description: >
      Mild facial weakness may be present, more commonly in autosomal recessive
      forms. Extraocular and bulbar muscle involvement is almost exclusively
      observed in the recessive group.
    frequency: HP_0040283
    phenotype_term:
      preferred_term: Myopathic facies
      term:
        id: HP:0002058
        label: Myopathic facies
    evidence:
      - reference: PMID:22473935
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Extraocular and bulbar muscle involvement was almost exclusively
          observed in the recessive group.
        explanation: >
          Demonstrates that facial and bulbar involvement is characteristic
          of recessive RYR1-related myopathies.
  - name: External ophthalmoplegia
    description: >
      External ophthalmoplegia is observed primarily in autosomal recessive
      forms of RYR1-related myopathy.
    frequency: HP_0040284
    phenotype_term:
      preferred_term: External ophthalmoplegia
      term:
        id: HP:0000544
        label: External ophthalmoplegia
    evidence:
      - reference: PMID:22473935
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Extraocular and bulbar muscle involvement was almost exclusively
          observed in the recessive group.
        explanation: >
          Extraocular involvement (ophthalmoplegia) is almost exclusively
          seen in recessive RYR1-related myopathies.
  - name: Respiratory insufficiency
    description: >
      Variable respiratory involvement may occur, particularly in more severe
      recessive forms, sometimes requiring respiratory support.
    frequency: HP_0040283
    phenotype_term:
      preferred_term: Respiratory insufficiency
      term:
        id: HP:0002093
        label: Respiratory insufficiency
    evidence:
      - reference: PMID:29391587
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          involvement of extraocular, cardiorespiratory and/or distal muscles
          can implicate specific genetic defects
        explanation: >
          Cardiorespiratory involvement is noted as a feature that can occur
          in congenital myopathies.
genetic:
  - name: RYR1 mutations
    association: Causative
    gene_term:
      preferred_term: RYR1
      description: >
        Ryanodine receptor 1, encoding a homotetrameric calcium release channel
        of 5,038 amino acids. Mapping to chromosome 19q13.2 and comprising 106
        exons, it is the principal skeletal muscle sarcoplasmic reticulum calcium
        release channel fundamental to excitation-contraction coupling.
      term:
        id: hgnc:10483
        label: RYR1
    notes: >
      RYR1 is the major causative gene for CCD. Over 300 pathogenic variants
      have been identified. Dominant mutations are typically missense changes
      clustered in recognized hotspot regions including the C-terminal
      pore-forming domain. Recessive mutations are distributed throughout the
      entire coding sequence and include nonsense and splice mutations expected
      to result in reduced RyR1 protein. RYR1 mutations are also the most
      frequent genetic cause of congenital myopathies overall.
    evidence:
      - reference: PMID:8220422
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          The only amino acid substitution found was an Arg2434His mutation,
          resulting from the substitution of A for G7301. This mutation was
          linked to CCD with a lod score of 4.8 at a recombinant fraction of
          0.0 in 16 informative meioses in a 130 member family, suggesting a
          causal relationship to CCD.
        explanation: >
          Landmark 1993 Nature Genetics paper that first identified a specific
          RYR1 mutation (Arg2434His) as causative of central core disease through
          linkage analysis in a large family.
      - reference: PMID:16917943
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Mapping to chromosome 19q13.2, the gene comprises 106 exons and
          encodes a protein of 5,038 amino acids. Mutations in the gene have
          been found in association with several diseases: the pharmacogenetic
          disorder, malignant hyperthermia (MH); and three congenital myopathies,
          including central core disease (CCD), multiminicore disease (MmD), and
          in an isolated case of a congenital myopathy characterized on histology
          by cores and rods.
        explanation: >
          Comprehensive review of RYR1 mutations establishing the gene structure
          and its association with CCD, MH, and other congenital myopathies.
      - reference: PMID:22473935
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Ryanodine receptor 1 (RYR1) mutations are a common cause of congenital
          myopathies associated with both dominant and recessive inheritance.
        explanation: >
          Large cohort study confirming RYR1 mutations as a common cause of
          congenital myopathies with both inheritance patterns.
      - reference: PMID:29391587
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          RYR1 mutations are the most frequent genetic cause, and CCD and MmD
          are the most common subgroups.
        explanation: >
          Nature Reviews Neurology review confirming RYR1 as the most frequent
          genetic cause of congenital myopathies.
treatments:
  - name: Avoidance of malignant hyperthermia triggers
    description: >
      Strict avoidance of volatile anesthetic agents (halothane, sevoflurane,
      desflurane, isoflurane) and depolarizing neuromuscular blocking agents
      (succinylcholine) during surgical procedures. Total intravenous anesthesia
      (TIVA) with agents such as propofol is recommended. Management must
      anticipate susceptibility to potentially life-threatening reactions to
      general anaesthesia.
    treatment_term:
      preferred_term: Anesthesia precautions
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Management is mainly supportive and has to anticipate susceptibility to
          potentially life-threatening reactions to general anaesthesia.
        explanation: >
          Establishes the critical importance of anesthetic precautions in CCD
          management.
  - name: Dantrolene for malignant hyperthermia
    description: >
      Dantrolene sodium is the specific treatment for acute malignant hyperthermia
      episodes. It acts by inhibiting calcium release from the sarcoplasmic
      reticulum via the ryanodine receptor. Dantrolene should be immediately
      available whenever a susceptible patient undergoes anesthesia.
    treatment_term:
      preferred_term: Dantrolene therapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
  - name: Physical therapy and rehabilitation
    description: >
      Regular physical therapy focusing on maintaining range of motion, preventing
      contractures, and maximizing functional capacity. Exercise programs should
      be tailored to individual ability.
    treatment_term:
      preferred_term: Physical therapy
      term:
        id: MAXO:0000011
        label: physical therapy
  - name: Orthopedic management
    description: >
      Surgical and conservative management of musculoskeletal complications
      including scoliosis, hip dislocation, and foot deformities. Bracing
      and assistive devices may be needed.
    treatment_term:
      preferred_term: Orthopedic surgery
      term:
        id: MAXO:0000004
        label: surgical procedure
  - name: Genetic counseling
    description: >
      Genetic counseling for affected families to discuss inheritance patterns,
      recurrence risk, and implications for family members regarding malignant
      hyperthermia susceptibility. Mutational analysis of RYR1 may provide
      genetic confirmation of the diagnosis.
    treatment_term:
      preferred_term: Genetic counseling
      term:
        id: MAXO:0000079
        label: genetic counseling
    evidence:
      - reference: PMID:17504518
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >
          Mutational analysis of the RYR1 gene may provide genetic confirmation
          of the diagnosis.
        explanation: >
          Supports the role of genetic testing and counseling in CCD diagnosis
          and family management.
notes: >
  Central core myopathy was first described by Shy and Magee in 1956 and was the
  first congenital myopathy defined by a specific histological abnormality. The
  molecular basis was established in 1993 when Zhang et al. and Quane et al.
  independently identified RYR1 mutations in CCD families. The disease has
  significant allelic overlap with malignant hyperthermia susceptibility (MHS1),
  and a single mutation may result in either or both phenotypes. The clinical
  spectrum of RYR1-related myopathies extends beyond central core disease to
  include multiminicore disease, centronuclear myopathy, and congenital fiber
  type disproportion, reflecting complex genotype-phenotype relationships. In
  the majority of patients, weakness is static or only slowly progressive, with
  a favourable long-term outcome. Prevalence is unknown but the condition is
  probably more common than other congenital myopathies.
datasets:
